• Piri Keşif Aracı

Arama ipuçları nelerdir?
1.  sayfa ve
1
COVID-19-associated encephalopathy: Neurological manifestation of COVID-19
Dergi Makalesi

Dergi Makalesi
Open Access
Kaynak :
Directory of Open Access Journals (DOAJ)
Dergi:
Radiology Case Reports
Yazar(lar) :
Safaa Saeed Al Mazrouei , MBBS , Ghufran Aref Saeed , MBBS , Abeer Ahmed Al Helali , MBBS , Manzoor Ahmed , MBBS
Yıl :
2020
COVID-19-associated encephalopathy: Neurological manifestation of COVID-19 Coronavirus disease 2019 ( COVID- 19) is a viral disease, also known as severe acute respiratory syndrome coronavirus 2, was first reported in Wuhan, China COVID- 19-associated neurological manifestations have not been widely reported. In this report, we describe a case of encephalopathy in a patient with COVID- 19 infection. Covid-19
Yayıncı Web Sitesi
Kaydet Alıntıla
Coronavirus disease 2019 (COVID-19) is a viral disease, also known as severe acute respiratory syndrome coronavirus 2, was first reported in Wuhan, China, December 2019. Respiratory manifestations from the induced acute lung injury were the most common reported findings. Few cases showed extrapulmonary manifestations. COVID-19-associated neurological manifestations have not been widely reported. In this report, we describe a case of encephalopathy in a patient with COVID-19 infection.
Anahtar Kelimeler : Covid-19, coronavirus, RT-PCR, reverse transcription polymerase chain reaction, central nervous system, Encephalopathy
ISSN: 1930-0433
Cilt: 15
Sayı: 9
Sayfa: 1646 - 1649
Sınıflandırma :
2
COVID-19 solution
Dergi Makalesi

Dergi Makalesi
Open Access
Kaynak :
Directory of Open Access Journals (DOAJ)
Dergi:
International Journal of Preventive Medicine
Yazar(lar) :
Roberto Menicagli , Mario Limodio
Yıl :
2020
COVID-19 solution Some CoVs have recently entered humans from infected animals and lastly we have SARS COVID- 19, (CoV), which causes severe acute, often fatal respiratory sars covid-19
Yayıncı Web Sitesi
 Piri Tam Metin Bulucu
Kaydet Alıntıla
Coronaviruses (CoV) are RNA viruses that cause endemic infections in various species of mammals and avian birds. There are seven known human CoVs, each of which causes respiratory diseases: together account for about one third of common colds. Some CoVs have recently entered humans from infected animals and lastly we have SARS COVID-19, (CoV), which causes severe acute, often fatal respiratory syndromes. The prevalence of CoV, the easy zoonotic transmission and the potential to cause serious respiratory diseases, lead to urgent research to discover the mechanisms of CoV infection. Our study has identified a possible way to eliminate the danger of this virus by analyzing the structures by which it enters the host cell. This study indicates that the neuroaminidase interrupts the infection.
DOI : 10.4103/ijpvm.IJPVM_227_20
Anahtar Kelimeler : neuroaminidase, sars covid-19, sialic acid
Cilt: 11
Sayı: 1
Sayfa: 73 - 73
Sınıflandırma :
Viroloji %95
3
Why COVID-19?
Dergi Makalesi

Dergi Makalesi
Open Access
Kaynak :
Directory of Open Access Journals (DOAJ)
Dergi:
Advanced Journal of Emergency Medicine
Yazar(lar) :
Elnaz Vahidi , Mohammad Jalili
Yıl :
2020
Why COVID-19? Covid- 19 has been estimated to have a case fatality rate of around 3%. In late December 2019, an outbreak of COVID- 19 was reported from Wuhan city, China. Today COVID- 19 has affected more than 212 countries and has made billions of people to be quarantined in their houses.
Yayıncı Web Sitesi
 Piri Tam Metin Bulucu
Kaydet Alıntıla
COVID-19 is a highly contagious disease caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), an enveloped positive stranded RNA virus and the third member of the family Coronaviridae which has emerged as a zoonotic infection. The predecessor of this new pathogen caused the Severe Acute Respiratory Syndrome (SARS) in 2003 and the Middle East Respiratory Syndrome (MERS) in 2012. Although corona viruses have been known since 1960’s, their familiar species were human pathogens and caused common cold and seasonal flu. SARS-CoV-2 is easily transmitted via respiratory secretions of an infected person, with a reproductive number (the average number of cases to which a single infected person will transmit the virus) of 1.4-2.5. Covid-19 has been estimated to have a case fatality rate of around 3%. As of today, asymptomatic transmission is assumed to be possible during the incubation period, which usually ranges from 2-14 days. The source of infection, animal host, and reservoir are currently unknown. In late December 2019, an outbreak of COVID-19 was reported from Wuhan city, China. The disease soon spread outside China borders and became rapidly prevalent all around the world. The pandemic announcement was officially made by World Health Organization (WHO) on 11 March 2020. Today COVID-19 has affected more than 212 countries and has made billions of people to be quarantined in their houses. Up to now, almost 1500000 confirmed cases of COVID-19 have been reported globally and the death toll has been declared to be 86000. In Iran, we are also facing this unprecedented global public health emergency, with about 65000 confirmed cases and 3993 deaths. This pandemic is beyond an expanding contagious disease and has influenced different features of life. Its enormous social, political, and specifically economic impacts all around the world are undeniable. In low- and middle-income countries this can potentially lead to a huge spike in poverty and collapse. Many vulnerable families have lost their income and access to the essential needs. Education systems have collapsed in many regions. The long-term effect of this global crisis has reduced economic growth even in developed countries. Economic effects of COVID-19 are estimated with dramatic variations. Orlik et al in Bloomberg hypothesized this cost to be $2.7 trillion. The political consequences are even harder to predict but quite significant and devastating, like the heated discussion, criticism and accusation flowing between the leaders of different countries. Since the pandemic is not yet over, the global influence will carry on to happen and make situation even more complicated. While the outbreak is evolving rapidly, health care systems across the world are actively fighting against the new virus. They have encountered many new challenges. Public health measures (such as active case finding, prompt isolation of cases and contacts tracing) to contain the spread of the disease in the society as well as provision of care for the unpredictably high number of people who are infected with the virus have stretched the healthcare system beyond its capacity. At the same time, protecting health care providers’ safety, which often requires provision of sufficient supplies of personal protective equipment, has definitely challenged the system. Societal demand for discovery of a definitive treatment and vaccine has also added to the complexity of the situation that the health care systems are facing. Studies about COVID-19 are increasingly being performed and published; many of them have not yet been fully reviewed and criticized by the academic community. Practitioners often find it difficult to find, appraise and apply the information they need amid the turbulence of their clinical practice. Furthermore, there are still many questions to be answered. The most efficient method for personal protection, methods of viral transmission, most accurate diagnostic approaches, and effective treatment options are yet to be determined. This special issue of the Advanced Journal of Emergency Medicine plans to specifically focus on COVID-19 by gathering the relevant scientific information available. We hope that by publishing high quality papers, this journal can provide its readers with further required information. Appropriate management of patients suffering COVID-19 as well as controlling this pandemic are our ultimate aspirations. We encourage further researches in this field by all scientists and physicians all across the world to be able to eradicate COVID-19 as soon as possible.
DOI : 10.22114/ajem.v0i0.402
ISSN: 2588-400X
Sınıflandırma :
Viroloji %77
4
Fighting COVID-19
Dergi Makalesi

Dergi Makalesi
Open Access
Kaynak :
Directory of Open Access Journals (DOAJ)
Dergi:
Brazilian Journal of Biology
Yazar(lar) :
D. M. O. Campos , C. B. S. Oliveira , J. M. A. Andrade , J. I. N. Oliveira
Fighting COVID-19 Abstract The current COVID- 19 pandemic caused by the novel coronavirus (SARS-CoV2) poses a threat to global health owing to its high rate of spread and covid-19
Yayıncı Web Sitesi
 Piri Tam Metin Bulucu
Kaydet Alıntıla
Abstract The current COVID-19 pandemic caused by the novel coronavirus (SARS-CoV2) poses a threat to global health owing to its high rate of spread and severe forms of respiratory infection. The lack of vaccines and antivirals prevents clinical strategies against the disease, creating an emerging need for the development of safe and effective treatments. Strategies for vaccine development include complete vaccines against viruses, subunits, and nucleic acids, but are still in their early stages. Studies carried out to date on possible SARS-CoV2 drug targets highlight glycoprotein S, Mpro (main protease or protease type 3C), and a member of the transmembrane serine protease II families (TMPRSS2). However, due to the pandemic state, priority is given to marketed drugs. These include chloroquine (CQ), hydroxychloroquine (HCQ), nitazoxanide, remdesivir, Lopinavir/ritonavir (LPV / r), in addition to treatment with convalescent plasma. But, therapeutic specific effects against SARS-CoV2 have not yet been verified. Most of the information obtained about treatment is based on preliminary and limited studies. We conclude that, at this time of emergency, the search for new therapies is more urgent due to the need to save lives. Thus, we point out as interesting targets for future more specific research: glycoprotein S, Mpro, and TMPRSS2.
DOI : 10.1590/1519-6984.238155
Anahtar Kelimeler : virology, sars-cov2, covid-19, infectious diseases
Sınıflandırma :
Biyotıp %100
Viroloji %99
5
Asymptomatic COVID-19 Infection Management: The Key to Stop COVID-19
Dergi Makalesi

Dergi Makalesi
Open Access
Kaynak :
Directory of Open Access Journals (DOAJ)
Dergi:
Journal of Clinical and Experimental Investigations
Yazar(lar) :
Rachid Ait Addi , Abdelhafid Benksim , Mohamed Amine , Mohamed Cherkaoui
Yıl :
2020
Asymptomatic COVID-19 Infection Management: The Key to Stop COVID-19 The COVID- 19 disease, emerged in December 2019, has spread rapidly, with new cases confirmed in multiple countries. portion of the population to virus and increase the late diagnosis and thereafter enhance COVID- 19 mortality. Thereafter, it is fundamental to review our COVID- 19 screening approach and enlarge COVID- 19 testing to the general population by using rapid testing appliances COVID-19
Yayıncı Web Sitesi
Tam Metin
Kaydet Alıntıla
The COVID-19 disease, emerged in December 2019, has spread rapidly, with new cases confirmed in multiple countries. Many efforts to contain the virus are ongoing, such as containment, individual measures of protection, the authorization of use of some drugs as chloquorine in some countries. Also, it has been known that symptomatic and asymptomatic people whom are infected by COVID-19 have the same contagiousness which expose a far greater portion of the population to virus and increase the late diagnosis and thereafter enhance COVID-19 mortality. Thereafter, it is fundamental to review our COVID-19 screening approach and enlarge COVID-19 testing to the general population by using rapid testing appliances such as rapid SARS-CoV-2 IgG-IgM combined antibody since another appliance more efficient will be performed.
DOI : 10.5799/jcei/7866
Anahtar Kelimeler : COVID-19, pandemic, screening, diagnosis
Cilt: 11
Sayı: 3
Sayfa:
Sınıflandırma :
6
COVID-19: Immunopathogenesis
Dergi Makalesi

Dergi Makalesi
Open Access
Kaynak :
Directory of Open Access Journals (DOAJ)
Dergi:
Flora Infeksiyon Hastalıkları ve Klinik Mikrobiyoloji Dergisi
Yazar(lar) :
Deniz MAVİ , Ahmet Çağkan İNKAYA
Yıl :
2020
COVID-19: Immunopathogenesis Coronavirus- 19 disease ( COVID- 19) first described in Wuhan, China at the end of 2019. respiratory syndrome coronavirus (SARS-CoV) and Middle East respiratory syndrome coronavirus (MERS-CoV) outbreaks may help to elucidate the pathogenesis of COVID - 19.
Yayıncı Web Sitesi
Tam Metin
Kaydet Alıntıla
Coronavirus-19 disease (COVID-19) first described in Wuhan, China at the end of 2019. It spread rapidly all over the world and claimed the lives of over 300,000 people. There is no known effective vaccine and treatment yet. It is impossible to develop vaccines and specific treatment without understanding the pathogenesis of the disease. Experience from severe acute respiratory syndrome coronavirus (SARS-CoV) and Middle East respiratory syndrome coronavirus (MERS-CoV) outbreaks may help to elucidate the pathogenesis of COVID-19. Nevertheless, many issues remained obscure regarding the pathogenesis of SARS-CoV-2. Exaggerated immune response leads to respiratory failure and even complications which may culminate in death. Cytokines storm, the complement system, endothelial damage, coagulation cascade, cellular and humoral immunity all play an important role in immune pathogenesis and inflammation. In this review, the relationship between the immune response/host characteristics of SARS-CoV-2 and the severity of the disease, antibody responses, and immune pathogenesis, possible causes of hypercoagulation will be discussed and it’s aimed to provide perspective on the development of effective vaccines and specific treatment.
DOI : 10.5578/flora.69606
Anahtar Kelimeler : sars-cov, sars-cov-2, immunopathogenesis, cytokine storm
ISSN: 1300-932X
Cilt: 25
Sayı: 2
Sayfa: 121 - 131
Sınıflandırma :
Viroloji %74
7
COVID 19: Neuromuscular manifestations
Dergi Makalesi

Dergi Makalesi
Open Access
Kaynak :
Directory of Open Access Journals (DOAJ)
Dergi:
Annals of Indian Academy of Neurology
Yazar(lar) :
Rajesh Benny , Satish V Khadilkar
Yıl :
2020
COVID 19: Neuromuscular manifestations COVID- 19 pandemic is ongoing and information on the neurological aspects of this viral infection is being gathered. This manuscript studies the available information on the neuromuscular manifestations of COVID- 19. covid-19 neurological manifestations covid-19 neuromuscular manifestations
Yayıncı Web Sitesi
 Piri Tam Metin Bulucu
Kaydet Alıntıla
COVID-19 pandemic is ongoing and information on the neurological aspects of this viral infection is being gathered. Neuromuscular manifestations have been reported uncommonly in these early stages of the analysis. This manuscript studies the available information on the neuromuscular manifestations of COVID-19.
DOI : 10.4103/aian.AIAN_309_20
Anahtar Kelimeler : covid-19 neurological manifestations, covid-19 neuromuscular manifestations, guillain barre syndrome, myositis
Cilt: 23
Sayı: 7
Sayfa: 40 - 42
Sınıflandırma :
Viroloji %27
8
Tobacco and COVID-19
Dergi Makalesi

Dergi Makalesi
Open Access
Kaynak :
Directory of Open Access Journals (DOAJ)
Dergi:
Eurasian Journal of Pulmonology
Yazar(lar) :
Ozlem Sonmez , Zeynep Atam Taşdemir , H Volkan Kara , Sule Akçay
Yıl :
2020
Tobacco and COVID-19 Similar data have been approved found for coronavirus disease-2019 ( COVID- 19) pandemic. adverse effects of tobacco and tobacco products and to raise awareness among the public and to make efforts to smoking on every opportunity during the COVID - 19 pandemic. covid-19
Yayıncı Web Sitesi
 Piri Tam Metin Bulucu
Kaydet Alıntıla
Tobacco and its products are the well-known causes of premature deaths associated with cancer, cardiovascular disease, and chronic obstructive pulmonary disease, as well as they constitute a significant risk factor that increases the tendency to respiratory system infection and other systemic infections. Active tobacco use and passive smoking increase the risk of infection. Both increase peribronchial and alveolar inflammation and fibrosis and mucosal permeability, cause inadequate mucociliary cleaning, damage to the respiratory tract epithelium resulting in fibrosis, and they adversely affect cellular and humoral immunity. Smoking has been known to increase the risk for viral infections and influenza. Similar data have been approved found for coronavirus disease-2019 (COVID-19) pandemic. Smoking is reported to be associated with the frequency of the disease and its severity of the clinical course. Severe acute respiratory syndrome-coronavirus-2 penetrates the cell using the angiotensin-converting enzyme 2 receptors. Such receptor proteins had been shown to increase in smoker individuals. Also, smoking facilitates penetration of the virus into the cell. The frequency of smoking and the rates of admission to intensive care, mechanical ventilation, and mortality have been also found to be higher was higher in severe cases. The risk for disease progression was found to be 14-fold higher in smokers. Further, the World Health Organization emphasized similar negative effects of hookah and new tobacco products such as electronic cigarettes and heated tobacco products. It is vital to underline the adverse effects of tobacco and tobacco products and to raise awareness among the public and to make efforts to smoking on every opportunity during the COVID-19 pandemic. Public awareness campaigns during the pandemic must always accompanied by the methods and strategies to avoid active and passive smoking.
DOI : 10.4103/ejop.ejop_52_20
Anahtar Kelimeler : covid-19, sars-cov-2, smoking, tobacco use
Cilt: 22
Sayı: 4
Sayfa: 12 - 15
Sınıflandırma :
9
Pathogenesis of COVID-19
Dergi Makalesi

Dergi Makalesi
Open Access
Kaynak 1:
Directory of Open Access Journals (DOAJ)
Kaynak 2:
Directory of Open Access Journals (DOAJ)
Dergi:
Eurasian Journal of Pulmonology
Yazar(lar) :
Evrim Eylem Akpinar
Yıl :
2020
Pathogenesis of COVID-19 The coronavirus disease 2019 ( COVID- 19) is a very contagious infectious disease which is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV The aim of this report is to review the immunopathogenesis of COVID- 19 in the light of current literature. covid-19
Piri Tam Metin Bulucu
Kaydet Alıntıla
The coronavirus disease 2019 (COVID-19) is a very contagious infectious disease which is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The virus is first identified in Wuhan city of China in December 2019 and in a short time dispersed to rest of the World. Animal to human transmission of the virus happened by eating of an infected animal and then the virus is transmitted to healthy persons by close contact. Coronaviruses attach and enter to the host cells by means of the spikes on the cell membrane. The type 2 pneumocytes are the primary target of the virus. The aim of this report is to review the immunopathogenesis of COVID-19 in the light of current literature.
DOI : 10.4103/ejop.ejop_54_20
Anahtar Kelimeler : coronavirus, covid-19, pathogenesis
Cilt: 22
Sayı: 4
Sayfa: 8 - 11
Sınıflandırma :
Viroloji %88
10
Acceptance of COVID-19 Vaccination during the COVID-19 Pandemic in China
Dergi Makalesi

Dergi Makalesi
Open Access
Kaynak :
Directory of Open Access Journals (DOAJ)
Dergi:
Vaccines
Yazar(lar) :
Jiahao Wang , Rize Jing , Xiaozhen Lai , Haijun Zhang , Yun Lyu , Maria Deloria Knoll , Hai Fang
Yıl :
2020
Acceptance of COVID-19 Vaccination during the COVID-19 Pandemic in China Background: Faced with the coronavirus disease 2019 ( COVID- 19) pandemic, the development of COVID- 19 vaccines has been progressing at an unprecedented of vaccines against COVID- 19 during the pandemic. - 19 vaccination or valuing doctor’s recommendations could increase the probability of accepting COVID- 19 vaccination as soon as possible, while having COVID-19
Yayıncı Web Sitesi
 Piri Tam Metin Bulucu
Kaydet Alıntıla
Background: Faced with the coronavirus disease 2019 (COVID-19) pandemic, the development of COVID-19 vaccines has been progressing at an unprecedented rate. This study aimed to evaluate the acceptance of COVID-19 vaccination in China and give suggestions for vaccination strategies and immunization programs accordingly. Methods: In March 2020, an anonymous cross-sectional survey was conducted online among Chinese adults. The questionnaire collected socio-demographic characteristics, risk perception, the impact of COVID-19, attitudes, acceptance and attribute preferences of vaccines against COVID-19 during the pandemic. Multivariate logistic regression was performed to identify the influencing factors of vaccination acceptance. Results: Of the 2058 participants surveyed, 1879 (91.3%) stated that they would accept COVID-19 vaccination after the vaccine becomes available, among whom 980 (52.2%) wanted to get vaccinated as soon as possible, while others (47.8%) would delay the vaccination until the vaccine’s safety was confirmed. Participants preferred a routine immunization schedule (49.4%) to emergency vaccination (9.0%) or either of them (41.6%). Logistic regression showed that being male, being married, perceiving a high risk of infection, being vaccinated against influenza in the past season, believing in the efficacy of COVID-19 vaccination or valuing doctor’s recommendations could increase the probability of accepting COVID-19 vaccination as soon as possible, while having confirmed or suspected cases in local areas, valuing vaccination convenience or vaccine price in decision-making could hinder participants from immediate vaccination. Conclusion: During the pandemic period, a strong demand for and high acceptance of COVID-19 vaccination has been shown among the Chinese population, while concerns about vaccine safety may hinder the promotion of vaccine uptake. To expand vaccination coverage, immunization programs should be designed to remove barriers in terms of vaccine price and vaccination convenience, and health education and communication from authoritative sources are important ways to alleviate public concerns about vaccine safety.
DOI : 10.3390/vaccines8030482
Anahtar Kelimeler : SARS-CoV-2, COVID-19, immunization, vaccine acceptance, vaccine preference
ISSN: 2076-393X
Cilt: 8
Sayı: 482
Sayfa: 482
Sınıflandırma :
11
COVID-19: immunopathogenesis and Immunotherapeutics
Dergi Makalesi

Dergi Makalesi
Open Access
Kaynak :
Directory of Open Access Journals (DOAJ)
Dergi:
Signal Transduction and Targeted Therapy
Yazar(lar) :
Li Yang , Shasha Liu , Jinyan Liu , Zhixin Zhang , Xiaochun Wan , Bo Huang , Youhai Chen , Yi Zhang
Yıl :
2020
COVID-19: immunopathogenesis and Immunotherapeutics Abstract The recent novel coronavirus disease ( COVID- 19) outbreak, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is seeing a Therefore, mechanisms underlying immune abnormalities in patients with COVID- 19 must be elucidated to guide clinical management of the disease. strategies against COVID- 19.
Yayıncı Web Sitesi
 Piri Tam Metin Bulucu
Kaydet Alıntıla
Abstract The recent novel coronavirus disease (COVID-19) outbreak, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is seeing a rapid increase in infected patients worldwide. The host immune response to SARS-CoV-2 appears to play a critical role in disease pathogenesis and clinical manifestations. SARS-CoV-2 not only activates antiviral immune responses, but can also cause uncontrolled inflammatory responses characterized by marked pro-inflammatory cytokine release in patients with severe COVID-19, leading to lymphopenia, lymphocyte dysfunction, and granulocyte and monocyte abnormalities. These SARS-CoV-2-induced immune abnormalities may lead to infections by microorganisms, septic shock, and severe multiple organ dysfunction. Therefore, mechanisms underlying immune abnormalities in patients with COVID-19 must be elucidated to guide clinical management of the disease. Moreover, rational management of the immune responses to SARS-CoV-2, which includes enhancing anti-viral immunity while inhibiting systemic inflammation, may be key to successful treatment. In this review, we discuss the immunopathology of COVID-19, its potential mechanisms, and clinical implications to aid the development of new therapeutic strategies against COVID-19.
DOI : 10.1038/s41392-020-00243-2
ISSN: 2059-3635
Cilt: 5
Sayı: 1
Sayfa: 1 - 8
Sınıflandırma :
Biyotıp %100
Viroloji %37
12
COVID-19 and our DNA
Dergi Makalesi

Dergi Makalesi
Open Access
Kaynak :
Directory of Open Access Journals (DOAJ)
Dergi:
The International Journal of Frontier Sciences
Yazar(lar) :
Muhammad Aslamkhan
Yıl :
2020
COVID-19 and our DNA covid-19
Yayıncı Web Sitesi
 Piri Tam Metin Bulucu
Kaydet Alıntıla
On December 31st 2019, Chinese Health Authorities in Wuhan city of their Hubei province, diagnosed 29 pneumonia cases of unknown etiology and informed WHO (World Health Organization). The unknown virus resembled SARS (severe acute respiratory syndrome), that occurred in China in November 2002, caused by a novel corona virus spilling over from an animal reservoir and transmitted by respiratory droplets. More than 8000 cases and 774 deaths were caused by SARS and circa US$20 billion coasted for its control.
DOI : 10.37978/tijfs.v4i2.206
Anahtar Kelimeler : covid-19, epidemic, epidemiology, genetic susceptibility, genome, pakistan, rna enveloped viruses, wuhan
Cilt: 4
Sayı: 2
Sayfa: 55 - 58
Sınıflandırma :
Viroloji %100
13
ACE2, Metformin, and COVID-19
Dergi Makalesi

Dergi Makalesi
Open Access
Kaynak :
Directory of Open Access Journals (DOAJ)
Dergi:
iScience
Yazar(lar) :
Atul Malhotra , Mark Hepokoski , Karen C. McCowen , John Y-J Shyy
Yıl :
2020
ACE2, Metformin, and COVID-19 Summary: COVID- 19 is becoming a leading cause of mortality throughout the world, and few effective therapies are currently available. Angiotensin converting enzyme 2 (ACE2) is essential to COVID- 19 pathogenesis, as the binding of SARS-CoV-2 spike protein (S protein) is required for viral entry and development of COVID- 19.
Yayıncı Web Sitesi
Kaydet Alıntıla
Summary: COVID-19 is becoming a leading cause of mortality throughout the world, and few effective therapies are currently available. Angiotensin converting enzyme 2 (ACE2) is essential to COVID-19 pathogenesis, as the binding of SARS-CoV-2 spike protein (S protein) is required for viral entry and development of COVID-19. ACE2 regulates the protective arm of the renin-angiotensin-aldosterone system (RAAS) that endows anti-hypertensive and anti-inflammatory effects in the cardiovascular and pulmonary systems. Preclinical data suggest ACE2 might be downregulated after SARS-CoV-2 binding, and treatments that increase ACE2 may prevent cardiopulmonary injury. Development, testing, and mass production of novel ACE2 therapies may take years, whereas more effective treatments for COVID-19 are needed urgently. Metformin is a widely available anti-diabetic agent that has an excellent safety profile, and clinical and preclinical data suggest metformin may offer cardiopulmonary protection in COVID-19 via enhanced ACE2 expression.
Anahtar Kelimeler : Virology, Endocrinology
ISSN: 2589-0042
Cilt: 23
Sayı: 9
Sayfa: 101425
Sınıflandırma :
Biyotıp %100
Viroloji %98
14
SARS-CoV-2(COVID-19)
Dergi Makalesi

Dergi Makalesi
Open Access
Kaynak :
Directory of Open Access Journals (DOAJ)
Dergi:
مجلة كلية الطب
Yazar(lar) :
Batool Ali Galib
Yıl :
2020
SARS-CoV-2(COVID-19) viruses to more severe diseases such as Severe Acute Respiratory Syndrome (SARS) during 2002, Middle East Respiratory Syndrome (MERS) during 2012, and the COVID - 19 that started during December 2019 in Wuhan, China.
Yayıncı Web Sitesi
Kaydet Alıntıla
Coronaviruses are a large family of viruses which may cause illness in animals or humans. In humans, seven strains of coronaviruses were recognized to cause respiratory infections ranging from the common cold associated with HKU1, NL63, OC43 and 229E viruses to more severe diseases such as Severe Acute Respiratory Syndrome (SARS) during 2002, Middle East Respiratory Syndrome (MERS) during 2012, and the COVID-19 that started during December 2019 in Wuhan, China. This is a review for the current pandemic
Cilt: 61
Sayı: 3,4
Sınıflandırma :
Viroloji %100
15
COVID-19: an updated review
Dergi Makalesi

Dergi Makalesi
Open Access
Kaynak :
Directory of Open Access Journals (DOAJ)
Dergi:
Infekciâ i Immunitet
Yazar(lar) :
F. A. Isihak , M. A. Hamad , N. G. Mustafa
Yıl :
2020
COVID-19: an updated review COVID- 19 is a zoonotic disease that showed higher levels of transmissibility in humans. So, all the world scientists today are in a race against time to find a vaccine or treatment to COVID- 19, which requires a deeper understanding. covid-19
Yayıncı Web Sitesi
 Piri Tam Metin Bulucu
Kaydet Alıntıla
COVID-19 is a zoonotic disease that showed higher levels of transmissibility in humans. Coronavirus has the largest recognized genome (28–33 kb) of a positive-sense single stranded RNA. The genome composed of 5′-end, the translationable mRNA sequences for the key proteins; replicase, spike, envelop membrane, and nucleocapsid and 3′-end (polyA tail). This highly contagious virus may impair the immune system in the early phase of the disease, hence the symptoms of the disease appear very rapidly. Importantly until now, there is no efficient strategy for containing the disease. So, all the world scientists today are in a race against time to find a vaccine or treatment to COVID-19, which requires a deeper understanding.
DOI : 10.15789/2220-7619-CAU-1443
Anahtar Kelimeler : covid-19, sars-cov-2, vaccination, virus structure, epidemiology, spikes
Cilt: 10
Sayı: 2
Sayfa: 247 - 258
Sınıflandırma :
16
From SARS to COVID-19: What we have learned about children infected with COVID-19
Dergi Makalesi

Dergi Makalesi
Open Access
Kaynak :
Directory of Open Access Journals (DOAJ)
Dergi:
International Journal of Infectious Diseases
Yazar(lar) :
Meng-Yao Zhou , Xiao-Li Xie , Yong-Gang Peng , Meng-Jun Wu , Xiao-Zhi Deng , Ying Wu , Li-Jing Xiong , Li-Hong Shang
Yıl :
2020
From SARS to COVID-19: What we have learned about children infected with COVID-19 There has been extensive research performed on SARS; however, the understanding of the pathophysiological impact of coronavirus disease 2019 ( COVID- 19) - 19. Newborns, asymptomatic children and normal chest imaging cases emerged in COVID- 19 literature. COVID-19
Yayıncı Web Sitesi
Kaydet Alıntıla
Introduction: Coronaviruses, both SARS-CoV and SARS-CoV-2, first appeared in China. They have certain biological, epidemiological and pathological similarities. To date, research has shown that their genes exhibit 79% of identical sequences and the receptor-binding domain structure is also very similar. There has been extensive research performed on SARS; however, the understanding of the pathophysiological impact of coronavirus disease 2019 (COVID-19) is still limited. Methods: This review drew upon the lessons learnt from SARS, in terms of epidemiology, clinical characteristics and pathogenesis, to further understand the features of COVID-19. Results: By comparing these two diseases, it found that COVID-19 has quicker and wider transmission, obvious family agglomeration, and higher morbidity and mortality. Newborns, asymptomatic children and normal chest imaging cases emerged in COVID-19 literature. Children starting with gastrointestinal symptoms may progress to severe conditions and newborns whose mothers are infected with COVID-19 could have severe complications. The laboratory test data showed that the percentage of neutrophils and the level of LDH is higher, and the number of CD4+ and CD8+T-cells is decreased in children's COVID-19 cases. Conclusion: Based on these early observations, as pediatricians, this review put forward some thoughts on children's COVID-19 and gave some recommendations to contain the disease.
Anahtar Kelimeler : Coronavirus, COVID-19, SARS-CoV-2, 2019-nCoV, Children
Cilt: 96
Sayfa: 710 - 714
Sınıflandırma :
17
Novel Coronavirus Infection: COVID-19
Dergi Makalesi

Dergi Makalesi
Open Access
Kaynak :
Directory of Open Access Journals (DOAJ)
Dergi:
Flora Infeksiyon Hastalıkları ve Klinik Mikrobiyoloji Dergisi
Yazar(lar) :
Ergin ÇİFTÇİ , Fevziye ÇOKSÜER
Yıl :
2020
Novel Coronavirus Infection: COVID-19 The most recent coronavirus, SARS-CoV-2, causing COVID- 19 disease was identified in 2019. There is no specific antiviral drug for COVID- 19 infection. The main protection measure is to avoid contact with the person infected with COVID- 19. covid-19
Yayıncı Web Sitesi
Tam Metin
Kaydet Alıntıla
Coronaviruses (CoV) are enveloped, single-chain positive RNA viruses constituting a fairly large family. 229E, OC43, NL63 and HKU1 species are common in humans, often causing mild to moderate respiratory infections. On the other hand, new coronaviruses have emerged, causing severe respiratory infection such as “severe acute respiratory syndrome” (SARS) in 2002 and “Middle East respiratory syndrome” (MERS) in 2012. The most recent coronavirus, SARS-CoV-2, causing COVID-19 disease was identified in 2019. While people of all ages are susceptible to COVID-19 infection, those with underlying chronic diseases and elderly age have increased susceptibility. There is no specific antiviral drug for COVID-19 infection. Therefore, treatment strategy is mostly aimed at supportive treatment and prevention of complications. The main protection measure is to avoid contact with the person infected with COVID-19. Following the identification of COVID-19 disease, it exceeded the region where it was located, the number of cases increased gradually, and intercontinental reports were made. COVID-19 is a highly pathogenic respiratory virus threatening global public health today. In order to eradicate the virus, it is necessary to clarify the source of the virus, to develop specific, effective treatments and a safe vaccine. Effective surveillance and appropriate infection control measures are critical to prevent the spread of the virüs.
DOI : 10.5578/flora.202002
Anahtar Kelimeler : coronavirus infections, covid-19, sars-cov-2
ISSN: 1300-932X
Cilt: 25
Sayı: 1
Sayfa: 9 - 18
Sınıflandırma :
Viroloji %75
18
COVID-19 and Neurological Manifestations
Dergi Makalesi

Dergi Makalesi
Open Access
Kaynak :
Directory of Open Access Journals (DOAJ)
Dergi:
Annals of the National Academy of Medical Sciences (India)
Yazar(lar) :
Neeraj Balaini , Manish Modi
Yıl :
2020
COVID-19 and Neurological Manifestations Coronavirus disease 2019 ( COVID- 19) is a viral illness caused by severe acute respiratory syndrome corona virus-2 (SARS-CoV-2) which has taken the form We therefore reviewed the neurological diseases or complications associated with COIVID- 19 in available literature. covid-19
Yayıncı Web Sitesi
 Piri Tam Metin Bulucu
Kaydet Alıntıla
Coronavirus disease 2019 (COVID-19) is a viral illness caused by severe acute respiratory syndrome corona virus-2 (SARS-CoV-2) which has taken the form of a pandemic. It mainly presents as fever, cough, shortness of breath involving respiratory system but neurological manifestations are increasingly being recognized worldwide and even virus RNA was demonstrated to be present in cerebrospinal fluid of a patient. SARS-CoV-2 involves both central nervous system and peripheral nervous system. Virus can enter the neural tissue from hematological route or through retrograde transport from nerve endings. Physicians especially neurologists should be aware regarding neurological manifestations as patient can present with these conditions in emergency. We therefore reviewed the neurological diseases or complications associated with COIVID-19 in available literature.
DOI : 10.1055/s-0040-1714153
Anahtar Kelimeler : coronavirus, covid-19, neurologic complications
Sınıflandırma :
Viroloji %72
19
Current strategies against COVID-19
Dergi Makalesi

Dergi Makalesi
Open Access
Kaynak :
Directory of Open Access Journals (DOAJ)
Dergi:
Chinese Medicine
Yazar(lar) :
Shahid Hussain , Ya-Jia Xie , Dan Li , Shaukat Iqbal Malik , Jin-cai Hou , Elaine Lai-Han Leung , Xing-Xing Fan
Yıl :
2020
Current strategies against COVID-19 Abstract Coronavirus disease ( COVID- 19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) recently was declared a pandemic by world This review will be not only helpful for the current situation of COVID- 19, but can also play a major role in such epidemics in the future. COVID-19
Yayıncı Web Sitesi
 Piri Tam Metin Bulucu
Kaydet Alıntıla
Abstract Coronavirus disease (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) recently was declared a pandemic by world health organization (WHO) Due to sudden outbreaks, currently, no completely effective vaccine or drug is clinically approved. Several therapeutic strategies can be envisaged to prevent further mortality and morbidity. Based on the past contribution of traditional Chinese medicines (TCM) and immune-based therapies as a treatment option in crucial pathogen outbreaks, we aimed to summarize potential therapeutic strategies that could be helpful to stop further spread of SARS-CoV-2 by effecting its structural components or modulation of immune responses. Several TCM with or without modification could be effective against the structural protein, enzymes, and nucleic acid should be tested from available libraries or to identify their immune-stimulatory activities to enhance several antiviral biological agents for effective elimination of SARS-CoV-2 from the host. TCM is not only effective in the direct inhibition of virus attachment and internalization in a cell but can also prevent their replication and can also help to boost up host immune response. Immune-modulatory effects of TCMs may lead to new medications and can guide us for the scientific validity of drug development. Besides, we also summarized the effective therapies in clinical for controlling inflammation. This review will be not only helpful for the current situation of COVID-19, but can also play a major role in such epidemics in the future.
DOI : 10.1186/s13020-020-00353-7
Anahtar Kelimeler : COVID-19, Therapeutic strategies, Traditional Chinese medicines, Immune-therapy
ISSN: 1749-8546
Cilt: 15
Sayı: 1
Sayfa: 1 - 12
Sınıflandırma :
Viroloji %48
20
COVID-19: Knowns, Unknowns, and Questions
Dergi Makalesi

Dergi Makalesi
Open Access
Kaynak :
Directory of Open Access Journals (DOAJ)
Dergi:
mSphere
Yazar(lar) :
Stuart Weston , Matthew B. Frieman
Yıl :
2020
COVID-19: Knowns, Unknowns, and Questions covid-19
Yayıncı Web Sitesi
 Piri Tam Metin Bulucu
Kaydet Alıntıla
The recent emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) from the Hubei province in China in late 2019 demonstrates the epidemic potential of coronaviruses. The rapid spread of this virus across the world in only 2 months highlights the transmissibility of this family of viruses and the significant morbidity and mortality that they can cause. We highlight the current state of knowledge of coronavirus biology while answering questions concerning the current outbreak of SARS-CoV-2.The recent emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) from the Hubei province in China in late 2019 demonstrates the epidemic potential of coronaviruses. The rapid spread of this virus across the world in only 2 months highlights the transmissibility of this family of viruses and the significant morbidity and mortality that they can cause. We highlight the current state of knowledge of coronavirus biology while answering questions concerning the current outbreak of SARS-CoV-2.
DOI : 10.1128/mSphere.00203-20
Anahtar Kelimeler : covid-19, coronavirus, sars-cov-2
ISSN: 2379-5042
Cilt: 5
Sayı: 2
Sayfa: e00203-20
Sınıflandırma :
Viroloji %71
21
Fundamental Basis of COVID-19 Pathogenesis
Dergi Makalesi

Dergi Makalesi
Open Access
Kaynak :
Directory of Open Access Journals (DOAJ)
Dergi:
Serbian Journal of Experimental and Clinical Research
Yazar(lar) :
Bolevich Sergey Brankovich , Litvitsky Peter Frantzevich , Grachev Sergei Vitalievich , Vorobyev Sergey Ivanovich , Orlova Alexandra Sergeevna , Fokina Marina Anatolievna , Novikov Alexei Alekseevich , Bolevich Stephani Sergeevna , Mikhaleva Anastasia Yurievna , Morozova Elena Mihailovna , Kartashova Maria Konstantinovna , Yavlieva Koka Hasbulatovna , Gudanovich Denis Vitalievich , Srejovic Ivan , Jakovljevic Vladimir
Yıl :
2020
Fundamental Basis of COVID-19 Pathogenesis On February 11th, 2020, the World Health Organization assigned the official name of the infection caused by the new coronavirus – COVID- 19. COVID- 19 has affected people from all over the world given that the infection was noted in 200 countries resulting in annunciation of the pandemic situation The initial stage of COVID- 19 infection is the penetration of SARS-CoV-2 into target cells that have angiotensin converting enzyme type II receptors. coronavirus – covid-19
Yayıncı Web Sitesi
 Piri Tam Metin Bulucu
Kaydet Alıntıla
At the end of 2019, a new coronavirus infection occurred in the People’s Republic of China with an epicentre in the city of Wuhan. On February 11th, 2020, the World Health Organization assigned the official name of the infection caused by the new coronavirus – COVID-19. COVID-19 has affected people from all over the world given that the infection was noted in 200 countries resulting in annunciation of the pandemic situation. Human corona viruses cause mild to moderate respiratory infections. At the end of 2002, a new coronavirus appeared (SARS-CoV), the causal agent of atypical pneumonia, which caused acute respiratory distress syndrome (ARDS). The initial stage of COVID-19 infection is the penetration of SARS-CoV-2 into target cells that have angiotensin converting enzyme type II receptors. The virus enters the body through the respiratory tract and interacts primarily with toll-like receptors (TLRs). The events in SARS-Cov-2 induced infection follow the next scenario: epithelial cells via TLRs recognize and identify SARS-Cov-2, and after that the information is transmitted to the transcriptional NF-κB, which causes expression of the corresponding genes. Activated in this way, the epithelial cells begin to synthesize various biologically active molecules. The results obtained on preclinical material indicate that ROS generation increases and the antioxidant protection decreases, which plays a major role in the pathogenesis of SARS-CoV, as well as in the progression and severity of this respiratory disease.
DOI : 10.2478/sjecr-2020-0029
Anahtar Kelimeler : world health organization, coronavirus u2013 covid-19, respiratory infection, respiratory distress syndrome
Cilt: 21
Sayı: 2
Sayfa: 93 - 111
Sınıflandırma :
Viroloji %72
22
COVID-19: etiology, clinical picture, treatment
Dergi Makalesi

Dergi Makalesi
Open Access
Kaynak :
Directory of Open Access Journals (DOAJ)
Dergi:
Infekciâ i Immunitet
Yazar(lar) :
M. Yu. Shchelkanov , L. V. Kolobukhina , O. A. Burgasova , I. S. Kruzhkova , V. V. Maleev
Yıl :
2020
COVID-19: etiology, clinical picture, treatment virus, its current taxonomy, ecology, virion morphology, life cycle, molecular biology, pathogenesis and clinical picture of the etiologically related COVID - 19 (Coronavirus disease 2019) as well as data available in the scientific literature on the anti-SARS-CoV-2-effectiveness of passive immunotherapy and most debated drugs used to treat COVID- 19: Chloroquine, Hydroxychloroquine, Nitazoxanide, Ivermectin, Lopinavir and Ritonavir, Camostat mesilate, Remdesivir covid-19
Yayıncı Web Sitesi
 Piri Tam Metin Bulucu
Kaydet Alıntıla
Whereas the XX century marked the history of acute respiratory disease investigation as a period for generating in-depth system of combating influenza viruses (Articulavirales: Orthomyxoviridae, Alpha-/Betainfluenzavirus) (based on environmental and virological monitoring of influenza A virus in its natural reservoir — aquatic and semi-aquatic birds — to supervising epidemic influenza), a similar system is necessary to build up in the XXI century with regard to especially dangerous betacoronaviruses (Nidovirales: Coronaviridae, Betacoronavirus): Severe acute respiratory syndrome-related coronavirus (SARS-CoV) (subgenus Sarbecovirus), Severe acute respiratory syndrome-related coronavirus 2 (SARSCoV-2) (Sarbecovirus), Middle East respiratory syndrome-related coronavirus (MERS-CoV) (Merbecovirus). This became particularly evident after pandemic potential has been revealed in 2020 by the SARS-CoV-2. This review provides an insight into the historic timeline of discovering this virus, its current taxonomy, ecology, virion morphology, life cycle, molecular biology, pathogenesis and clinical picture of the etiologically related COVID-19 (Coronavirus disease 2019) as well as data available in the scientific literature on the anti-SARS-CoV-2-effectiveness of passive immunotherapy and most debated drugs used to treat COVID-19: Chloroquine, Hydroxychloroquine, Nitazoxanide, Ivermectin, Lopinavir and Ritonavir, Camostat mesilate, Remdesivir, Ribavirin, Tocilizumab, Anakinra, corticosteroids, and type I interferons. The pathogenesis of SARS-CoV-2 infection implicates decreased efficacy of artificial respiration, which, in this case might be replaced by more efficient extracorporeal membrane blood oxygenation supplemented with nitrogen oxide and/or Heliox inhalations.
DOI : 10.15789/2220-7619-CEC-1473
Anahtar Kelimeler : covid-19, sars-cov-2, 2019-ncov, coronavirus, nidovirales, coronaviridae, betacoronavirus, sarbecovirus, clinical features, pathogenesis, treatment
Cilt: 10
Sayı: 3
Sayfa: 421 - 445
Sınıflandırma :
Viroloji %94
23
The hallmarks of COVID-19 disease.
Dergi Makalesi

Dergi Makalesi
Open Access
Kaynak :
Directory of Open Access Journals (DOAJ)
Dergi:
PLoS Pathogens
Yazar(lar) :
Daolin Tang , Paul Comish , Rui Kang
Yıl :
2020
The hallmarks of COVID-19 disease. The clinical features of COVID- 19, such as fever, cough, shortness of breath, and fatigue, are similar to those of many acute respiratory infections. There is currently no specific treatment for COVID- 19, but antiviral therapy combined with supportive care is the main strategy. Here, we summarize recent progress in understanding the epidemiological, virological, and clinical characteristics of COVID- 19 and discuss potential targets
Yayıncı Web Sitesi
 Piri Tam Metin Bulucu
Kaydet Alıntıla
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is a novel coronavirus that has caused a worldwide pandemic of the human respiratory illness COVID-19, resulting in a severe threat to public health and safety. Analysis of the genetic tree suggests that SARS-CoV-2 belongs to the same Betacoronavirus group as severe acute respiratory syndrome coronavirus (SARS-CoV) and Middle East respiratory syndrome coronavirus (MERS-CoV). Although the route for viral transmission remains a mystery, SARS-CoV-2 may have originated in an animal reservoir, likely that of bat. The clinical features of COVID-19, such as fever, cough, shortness of breath, and fatigue, are similar to those of many acute respiratory infections. There is currently no specific treatment for COVID-19, but antiviral therapy combined with supportive care is the main strategy. Here, we summarize recent progress in understanding the epidemiological, virological, and clinical characteristics of COVID-19 and discuss potential targets with existing drugs for the treatment of this emerging zoonotic disease.
DOI : 10.1371/journal.ppat.1008536
Cilt: 16
Sayı: 5
Sayfa: e1008536
Sınıflandırma :
Viroloji %100
24
COVID‐19 diagnostic testing: Technology perspective
Dergi Makalesi

Dergi Makalesi
Open Access
Kaynak :
Directory of Open Access Journals (DOAJ)
Dergi:
Clinical and Translational Medicine
Yazar(lar) :
Meng Xu , Dan Wang , Hongye Wang , Xiaomei Zhang , Te Liang , Jiayu Dai , Meng Li , Jiahui Zhang , Kai Zhang , Danke Xu , Xiaobo Yu
Yıl :
2020
COVID‐19 diagnostic testing: Technology perspective Abstract The corona virus disease 2019 ( COVID‐ 19) is a highly contagious disease caused by the severe acute respiratory syndrome coronavirus 2 (SARS‐CoV Controlling the spread of SARS‐CoV‐2 is therefore inherently dependent on identifying and isolating infected individuals, especially since COVID‐ 19 can Here, we provide a comprehensive review of the different primary technologies used to test for COVID‐ 19 infection, discuss the advantages and disadvantages COVID‐19
Yayıncı Web Sitesi
 Piri Tam Metin Bulucu
Kaydet Alıntıla
Abstract The corona virus disease 2019 (COVID‐19) is a highly contagious disease caused by the severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2). More than 18 million people were infected with a total of 0.7 million deaths in ∼188 countries. Controlling the spread of SARS‐CoV‐2 is therefore inherently dependent on identifying and isolating infected individuals, especially since COVID‐19 can result in little to no symptoms. Here, we provide a comprehensive review of the different primary technologies used to test for COVID‐19 infection, discuss the advantages and disadvantages of each technology, and highlight the studies that have employed them. We also describe technologies that have the potential to accelerate SARS‐CoV‐2 detection in the future, including digital PCR, CRISPR, and microarray. Finally, remaining challenges in COVID‐19 diagnostic testing are discussed, including (a) the lack of universal standards for diagnostic testing; (b) the identification of appropriate sample collection site(s); (c) the difficulty in performing large population screening; and (d) the limited understanding of SARS‐COV‐2 viral invasion, replication, and transmission.
DOI : 10.1002/ctm2.158
Anahtar Kelimeler : COVIDu201019, diagnostic test, nucleic acid, SARSu2010COVu20102, serum
ISSN: 2001-1326
Cilt: 10
Sayı: 4
Sınıflandırma :
25
Current Avenues for COVID-19 Serology
Dergi Makalesi

Dergi Makalesi
Open Access
Kaynak :
Directory of Open Access Journals (DOAJ)
Dergi:
Annals of the National Academy of Medical Sciences (India)
Yazar(lar) :
Saumya Srivastava , Vidhi Jain , Vijaya Lakshmi Nag , Sanjeev Misra , Kuldeep Singh
Yıl :
2020
Current Avenues for COVID-19 Serology Development of rapid, reliable, and easy diagnostic tests with high-throughput is the need of the hour for laboratories combating the COVID- 19 pandemic Timely diagnosis, effective treatment, and future prevention are key to management of COVID- 19. covid-19 serological tests
Yayıncı Web Sitesi
 Piri Tam Metin Bulucu
Kaydet Alıntıla
Development of rapid, reliable, and easy diagnostic tests with high-throughput is the need of the hour for laboratories combating the COVID-19 pandemic. While real-time polymerase chain reaction (RT-PCR) is the gold standard for diagnosing active infections, it is expensive and time-consuming. Serological diagnostic assays with a premise to aid rapid contact tracing, immune status determination, and identification of potential convalescent plasma donors hold great promise. Timely diagnosis, effective treatment, and future prevention are key to management of COVID-19.
DOI : 10.1055/s-0040-1713709
Anahtar Kelimeler : rapid diagnostic tests, covid-19 serological tests, convalescent plasma, immune status, antibody test
Cilt: 56
Sayı: 02
Sayfa: 087 - 090
Sınıflandırma :
26
Immune responses during COVID-19 infection
Dergi Makalesi

Dergi Makalesi
Open Access
Kaynak :
Directory of Open Access Journals (DOAJ)
Dergi:
OncoImmunology
Yazar(lar) :
Cléa Melenotte , Aymeric Silvin , Anne-Gaëlle Goubet , Imran Lahmar , Agathe Dubuisson , Alimuddin Zumla , Didier Raoult , Mansouria Merad , Bertrand Gachot , Clémence Hénon , Eric Solary , Michaela Fontenay , Fabrice André , Markus Maeurer , Giuseppe Ippolito , Mauro Piacentini , Fu-Sheng Wang , Florent Ginhoux , Aurélien Marabelle , Guido Kroemer , Lisa Derosa , Laurence Zitvogel
Yıl :
2020
Immune responses during COVID-19 infection The unpredictability of coronavirus disease- 19 ( COVID- 19) poses a major burden on health care and economic systems across the world. This is caused by the paucity of in-depth knowledge of the risk factors for severe COVID- 19, insufficient diagnostic tools for the detection of SARS-CoV covid-19
Yayıncı Web Sitesi
 Piri Tam Metin Bulucu
Kaydet Alıntıla
Over the past 16 years, three coronaviruses (CoVs), severe acute respiratory syndrome CoV (SARS-CoV) in 2002, Middle East respiratory syndrome CoV (MERS-CoV) in 2012 and 2015, and SARS-CoV-2 in 2020, have been causing severe and fatal human epidemics. The unpredictability of coronavirus disease-19 (COVID-19) poses a major burden on health care and economic systems across the world. This is caused by the paucity of in-depth knowledge of the risk factors for severe COVID-19, insufficient diagnostic tools for the detection of SARS-CoV-2, as well as the absence of specific and effective drug treatments. While protective humoral and cellular immune responses are usually mounted against these betacoronaviruses, immune responses to SARS-CoV2 sometimes derail towards inflammatory tissue damage, leading to rapid admissions to intensive care units. The lack of knowledge on mechanisms that tilt the balance between these two opposite outcomes poses major threats to many ongoing clinical trials dealing with immunostimulatory or immunoregulatory therapeutics. This review will discuss innate and cognate immune responses underlying protective or deleterious immune reactions against these pathogenic coronaviruses.
DOI : 10.1080/2162402X.2020.1807836
Anahtar Kelimeler : covid-19, sars-cov-2, coronavirus, immune response, immunity, cellular, humoral
ISSN: 2162-402X
Cilt: 9
Sayı: 1
Sınıflandırma :
Viroloji %82
27
Macrophage activation syndrome and COVID-19
Dergi Makalesi

Dergi Makalesi
Open Access
Kaynak :
Directory of Open Access Journals (DOAJ)
Dergi:
Inflammation and Regeneration
Yazar(lar) :
Ryo Otsuka , Ken-ichiro Seino
Yıl :
2020
Macrophage activation syndrome and COVID-19 Severe COVID- 19 is often associated with hypercytokinemia, which is typically found in macrophage activation syndrome. Although we have not fully understood the physiological and pathological aspects of COVID- 19, current research progress indicates the effectiveness of Here, we summarize macrophage activation syndrome and its possible contribution to COVID- 19, and cytokine targeted attempts in severe COVID- 19 cases. COVID-19
Yayıncı Web Sitesi
 Piri Tam Metin Bulucu
Kaydet Alıntıla
Abstract An emerging, rapidly spreading coronavirus SARS-CoV-2 is causing a devastating pandemic. As we have not developed curative medicine and effective vaccine, the end of this life-threatening infectious disease is still unclear. Severe COVID-19 is often associated with hypercytokinemia, which is typically found in macrophage activation syndrome. SARS-CoV-2 infection causes this strong inflammation within the lung and propagates to respiratory and, ultimately, systemic organ malfunction. Although we have not fully understood the physiological and pathological aspects of COVID-19, current research progress indicates the effectiveness of anti-cytokine therapy. Here, we summarize macrophage activation syndrome and its possible contribution to COVID-19, and cytokine targeted attempts in severe COVID-19 cases.
DOI : 10.1186/s41232-020-00131-w
Anahtar Kelimeler : COVID-19, SARS-CoV-2, Macrophage activation syndrome, Cytokine storm, Anti-cytokine therapy
ISSN: 1880-8190
Cilt: 40
Sayı: 1
Sayfa: 1 - 6
Sınıflandırma :
Viroloji %21
28
COVID-19 Therapeutic Options Under Investigation
Dergi Makalesi

Dergi Makalesi
Open Access
Kaynak :
Directory of Open Access Journals (DOAJ)
Dergi:
Frontiers in Pharmacology
Yazar(lar) :
Malak Kaddoura , Malak Kaddoura , Malak AlIbrahim , Malak AlIbrahim , Ghina Hijazi , Ghina Hijazi , Nadia Soudani , Nadia Soudani , Amani Audi , Amani Audi , Habib Alkalamouni , Habib Alkalamouni , Salame Haddad , Salame Haddad , Ali Eid , Hassan Zaraket , Hassan Zaraket
Yıl :
2020
COVID-19 Therapeutic Options Under Investigation Since its emergence in China in December 2019, COVID- 19 has quickly spread around the globe causing a pandemic. Two compounds, remdesivir, and dexamethasone have been so far shown to reduce COVID- 19–associated death. Here, we provide a review of the potential therapeutic agents being considered for the treatment and management of COVID- 19 patients. COVID-19
Yayıncı Web Sitesi
 Piri Tam Metin Bulucu
Kaydet Alıntıla
Since its emergence in China in December 2019, COVID-19 has quickly spread around the globe causing a pandemic. Vaccination or the development of herd immunity seems the only way to slow down the spread of the virus; however, both are not achievable in the near future. Therefore, effective treatments to mitigate the burden of this pandemic and reduce mortality rates are urgently needed. Preclinical and clinical studies of potential antiviral and immunomodulatory compounds and molecules to identify safe and efficacious therapeutics for COVID-19 are ongoing. Two compounds, remdesivir, and dexamethasone have been so far shown to reduce COVID-19–associated death. Here, we provide a review of the potential therapeutic agents being considered for the treatment and management of COVID-19 patients.
DOI : 10.3389/fphar.2020.01196
Anahtar Kelimeler : SARS-CoV-2, COVID-19, antivirals, adjunctive therapy, therapeutics
ISSN: 1663-9812
Cilt: 11
Sınıflandırma :
29
COVID-19 remedies
Dergi Makalesi

Dergi Makalesi
Open Access
Kaynak :
Springer Nature
Dergi:
Nature Biomedical Engineering
Yayıncı:
Springer Nature
Konu :
Biomedicine, general, Biomedical Engineering/Biotechnology
Yıl :
2020
COVID-19 remedies Repurposed drugs, inhibitors of inflammatory cytokines, neutralizing monoclonal antibodies and sera from convalescent patients will help ease the burden of COVID - 19 on healthcare systems.
Yayıncı Web Sitesi
Tam Metin
Kaydet Alıntıla
Repurposed drugs, inhibitors of inflammatory cytokines, neutralizing monoclonal antibodies and sera from convalescent patients will help ease the burden of COVID-19 on healthcare systems.
DOI : 10.1038/s41551-020-0579-9
ISSN: 2157-846X
Cilt: 4
Sayı: 6
Sayfa: 575-576
Sınıflandırma :

Yayın Yılı

Sınırla

Doküman Türü
Tümü

Veri Tabanı
Tümü

Dergi İsmi
Tümü

Disiplin
Tümü

Disipline Göre İlgililik

Alt Disiplin
Tümü

Konu
Tümü

Yayıncı
Tümü

Lisan
Tümü

X
Filtreler